Lyka Labs Limited (BOM:500259)
India · Delayed Price · Currency is INR 75.03
-3.33 (-4.25%)
At close: Oct 6, 2026
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.69 billion as of October 7, 2026. Its market cap has decreased by 21.37% in one year.
Market Cap
2.69B
Enterprise Value
3.14B
Revenue
1.34B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.69B, an increase of 811.72%. That is a compound annual growth rate of 10.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.69B | -0.83% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medicamen Biotech | 4.28B |
| Jenburkt Pharmaceuticals | 4.08B |
| Astonea Labs | 3.63B |
| Ambalal Sarabhai Enterprises | 2.91B |
| Sat Kartar Life | 2.90B |
| BDH Industries | 2.78B |
| Gennex Laboratories | 2.38B |
| Bilcare | 2.38B |